Coagulation blockade prevents sepsis-induced respiratory and renal failure in baboons

American Journal of Respiratory and Critical Care Medicine

Volumn 164, Issue 10 I, 2001, Pages 1988-1996

  Welty Wolf, Karen E ^a   Carraway, Martha S ^b   Miller, Debra L ^b   Ortel, Thomas L ^b   Ezban, Mirella ^b   Ghio, Andrew J ^b   Idell, Steven ^b   Piantadosi, Claude A ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

Adult respiratory distress syndrome; Multiple organ failure; Papio; Septicemia; Thromboplastin

Indexed keywords

BLOOD CLOTTING FACTOR 7A; CYTOKINE; FIBRIN; FIBRINOGEN; INTERLEUKIN 6; PROCOAGULANT; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BABOON; BLOOD CLOTTING; CONTROLLED STUDY; CYTOKINE RELEASE; ESCHERICHIA COLI; FIBRIN DEPOSITION; GAS EXCHANGE; KIDNEY FAILURE; KIDNEY FUNCTION; LUNG COMPLIANCE; LUNG EDEMA; LUNG INJURY; MALE; MULTIPLE ORGAN FAILURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; RESPIRATORY FAILURE; SEPSIS;

EID: 0035891597     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.164.10.2105027     Document Type: Article

References (50)

1. Structural alterations of lung parenchyma in the adult respiratory distress syndrome
2. Extravascular coagulation and fibrin deposition in acute lung injury
3. Efficacy and safety of recombinant human activated protein C for severe sepsis
4. Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock
5. Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody
6. Antithrombin-III prevents the lethal effects of Escherichia coli infusion in baboons
7. Bacterial priming increases lung injury in gram negative sepsis
8. Antibody to E- and L-selectin does not prevent lung injury or mortality in septic baboons
9. Pro-inflammatory cytokines increase in sepsis after antiadhesion molecule therapy
10. Antibody to intercellular adhesion molecule-1 (CD54) decreases survival and not lung injury in baboons with sepsis
11. Experimental endotoxemia in humans: Analysis of cytokine release and coagulation, fibrinolytic, and complement pathways
12. Complete inhibition of endotoxin-induced coagulation activation in chimpanzees with a monoclonal Fab fragment against factor VII/VIIa
13. Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxyphylline or by a monoclonal anti-tissue factor antibody in chimpanzees
14. The in vivo kinetics of tissue factor messenger RNA expression during human endotoxemia: Relationship with activation of coagulation
15. Elimination of IL-6 attenuates coagulation activation in experimental endotoxemia in chimpanzees
16. Differential effects of anti-tumor necrosis factor monoclonal antibodies on systemic inflammatory responses in experimental endotoxemia in chimpanzees
17. Local abnormalities of coagulation and fibrinolytic pathways that promote alveolar fibrin deposition in the lungs of baboons with diffuse alveolar damage
18. Differential effects of anti-cytokine treatment on bronchoalveolar hemostasis in endotoxemic chimpanzees
19. Serial abnormalities of fibrin turnover in evolving adult respiratory distress syndrome
20. Tissue factor-dependent vascular endothelial growth factor production by human fibroblasts in response to activated factor VII
21. Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration
22. Potential mechanisms for a proinflammatory vascular cytokine response to coagulation activation
23. Early detection of type III procollagen peptide in acute lung injury
24. Incorporation of an active site inhibitor in factor VIIa alters the affinity for tissue factor
25. Recombinant human antithrombin III improves survival and attenuates inflammatory responses in baboons lethally challenged with Escherichia coli
26. 100 Escherichia coli
27. Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in baboons
28. Pulmonary and oxygen transport effects of intravenously administered endotoxin in normal humans
29. Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa
30. Alteration of surfactant function due to protein leakage: Special interaction with fibrin monomer
31. Macrophage migration in fibrin gel matrices
32. Cell surface fibrinogen-fibrin receptors on cultured human fibroblasts: Association with fibronectin (cold insoluble globulin, LETS protein) and loss in SV40 transformed cells
33. The protein C pathway
34. Coagulation inhibitor replacement during sepsis: Useless?
35. Tissue factor and factor VIIa receptor/ligand interactions induce proinflamatory effects in macrophages
36. Tissue factor in bronchoalveolar lavage fluids. Evidence for an alveolar macrophage source
37. Glomerular tissue factor expression in crescentic glomerulonephritis. Correlations between antigen, activity, and mRNA
38. Structural design and molecular evolution of a cytokinereceptor superfamily
39. Signal transduction via the mitogen-activated protein kinase pathway induced by binding of coagulation factor FVIIa to tissue factor
40. Binding of factor VIIa to tissue factor on keratinocytes induces gene expression
41. Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome
42. Endothelin 1 and thrombin synergistically stimulate IL-6 mRNA expression and protein production in human umbilical vein endothelial cells
43. Protease-activated receptors and their role in IL-6 and NF-IL-6 expression in human gingival fibroblasts
44. Effect of human recombinant interleukin-6 and interleukin-8 on monocyte procoagulant activity
45. Regulation of vascular endothelial growth factor production and angiogenesis by the cytoplasmic tail of tissue factor
46. Clinical trial results with antithrombin III in sepsis
47. DEGR-factor Xa blocks disseminated intravascular coagulation initiated by Escherichia coli without preventing shock or organ damage
48. Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia
49. Effect of locally-applied active site-blocked activated factor VII (ASIS) on experimental arterial thrombosis
50. Low levels of tissue factor are compatible with development and hemostasis in mice